comparemela.com

Yaoxing Huang News Today : Breaking News, Live Updates & Top Stories | Vimarsana

RenBio Announces the Award of Two Grants to Support Continued Development of Its Novel DNA Therapeutics MYO Technology™ Platform for Infectious Disease Applications

RenBio Announces the Award of Two Grants to Support Continued Development of Its Novel DNA Therapeutics MYO Technology™ Platform for Infectious Disease Applications - read this article along with other careers information, tips and advice on BioSpace

New yorkUnited statesPaula schwartzNealn padteYaoxing huangRachela liberatoreJamese crowe jrPrnewswire renbioVanderbilt university medical centerAwardee of vanderbilt university underMelinda gates foundationEmpire state developmentRx communications groupYork state biodefense commercialization fundYour own technologyColumbia university professors davidd ho

RenBio Announces the Award of Two Grants to Support Continued Development of Its Novel DNA Therapeutics MYO Technology™ Platform for Infectious Disease Applications

RenBio Announces the Award of Two Grants to Support Continued Development of Its Novel DNA Therapeutics MYO Technology™ Platform for Infectious Disease Applications
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesNealn padteYaoxing huangRachela liberatoreJamese crowe jrPrnewswire renbioVanderbilt university medical centerAwardee of vanderbilt university underMelinda gates foundationEmpire state developmentYork state biodefense commercialization fundYour own technologyColumbia university professors davidd hoDefense advanced research projects agencyVanderbilt vaccine center

RenBio Announces the Award of Two Grants to Support Continued Development of Its Novel DNA Therapeutics MYO Technology™ Platform for Infectious Disease Applications

/PRNewswire/ RenBio, a privately-held, preclinical biotechnology company leveraging its novel, proprietary MYO (Make Your Own) Technology™ platform to.

New yorkUnited statesPaula schwartzNealn padteYaoxing huangRachela liberatoreJamese crowe jrPrnewswire renbioVanderbilt university medical centerAwardee of vanderbilt university underMelinda gates foundationEmpire state developmentRx communications groupYork state biodefense commercialization fundYour own technologyColumbia university professors davidd ho

Dominant Omicron Subvariants Better at Evading Vaccines, Antibody Treatments

Dominant Omicron Subvariants Better at Evading Vaccines, Antibody Treatments
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United statesJian yuQian wangYicheng guoKathrine meyersHiroshi mohriJennifery changCarol ludwigMagdalenae sobieszczykMaple wangYaoxing huangZizhang shengManojs nairNadia nguyenAnthonyd bowenZhiteng li

RenBio Completes $24 Million Series A Financing and Licenses Novel SARS-CoV-2 Bispecific Antibody from Columbia University

Share this article NEW YORK, May 20, 2021 /PRNewswire/ RenBio, a privately-held, preclinical biotechnology company developing novel, best-in-class antiviral antibody therapeutics and a next-generation antibody delivery platform, today announced that it has completed a $24 million Series A financing, led by Taiwan-based Ruentex Group. The company has also signed a license agreement with Columbia University, giving RenBio the exclusive worldwide development and commercialization rights to a novel bispecific antibody (RB-100) for COVID-19 that was developed in the lab of David D. Ho, M.D. of Columbia University and targets two distinct sites on the spike of SARS-CoV-2. In preclinical studies, RB-100 demonstrated robust antiviral activity against SARS-CoV-2 variants that have recently emerged from the U.K. (B.1.1.7), South Africa (B.1.351), Brazil (P.1), California (B.1.427 and B.1.429), and New York City (B.1.526).

Columbia universityNew yorkUnited statesSouth africaPaula schwartzNealn padteYaoxing huangRachela liberatoreRuentex groupResearch centerMelinda gates foundationRx communications groupYour own technologyLewis bockiusDefense advanced research projects agencyColumbia university vagelos college of physicians

vimarsana © 2020. All Rights Reserved.